Express News | Olin Biotech: Quadrivalent influenza virus lysis vaccine (MDCK cells) received approval notice for drug clinical trials

BreakingsMay 15 06:17

Olin Insiders Sold US$22m Of Shares Suggesting Hesitancy

Many Olin Corporation (NYSE:OLN) insiders ditched their stock over the past year, which may be of interest to the company's shareholders. When analyzing insider transactions, it is usually more valu

Simply Wall StMay 12 09:15

Olin Corp's Dividend Analysis

Yahoo FinanceMay 7 06:04

Should You Buy Olin Corporation (NYSE:OLN) For Its Upcoming Dividend?

Yahoo FinanceMay 5 07:37

Form 144 | Olin(OLN.US) Insider Proposes to Sell 13.81 Million in Common Stocks

SEC FILLINGS DISCLOSED/ Apr 29, $Olin(OLN.US)$ Insider Scott M. Sutton intends to sell 258.19K shares of its common stock on Apr 30, with a total market value of approximately $13.81 million. Scott

Futu NewsApr 29 15:48

Piper Sandler Adjusts Price Target on Olin to $75 From $72, Maintains Overweight Rating

Olin (OLN) has an average rating of outperform and price targets ranging from $41 to $73, according to analysts polled by Capital IQ. Price: 53.67, Change: +0.19, Percent Change: +0.36

MT NewswiresApr 29 09:55